Huang Huang

Huang Huang

University of Toronto - Toronto / Canada
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 664205
person_outline Huang Huang's MOST POPULAR ARTICLES
1-) Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 studyLE Budde, LH Sehn, M Matasar, SJ Schuster, S Assouline, P Giri, ...The Lancet Oncology 23 (8), 1055-1065, 20222512022
2-) Single-agent mosunetuzumab shows durable complete responses in patients with relapsed or refractory B-cell lymphomas: phase I dose-escalation studyLE Budde, NL BartlettAmerican Society of Clinical Oncology 40 (5), 481, 20222492022
3-) A PEGylation-free biomimetic porphyrin nanoplatform for personalized cancer theranosticsL Cui, Q Lin, CS Jin, W Jiang, H Huang, L Ding, N Muhanna, JC Irish, ...ACS nano 9 (4), 4484-4495, 20151762015
4-) Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemiaIW Flinn, JG Gribben, MJS Dyer, W Wierda, MB Maris, RR Furman, ...Blood, The Journal of the American Society of Hematology 133 (26), 2765-2775, 2019842019
5-) Learning from biology: synthetic lipoproteins for drug deliveryH Huang, W Cruz, J Chen, G ZhengWiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 7 (3 …, 2015752015